Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 13, 2021 Filed Oct 15, 2021 20:24 UTC |
POYHONEN JOHNPresident & CCO
|
Exercise / conversionRestricted Stock Units · Derivative | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-060550 · doc4.xml · derivative · entry 3 POYHONEN JOHN · CIK 0001286100 · President & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 1,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020). F3 · derivative.expiration_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020). Read SEC document |
| October 13, 2021 Filed Oct 15, 2021 20:24 UTC |
POYHONEN JOHNPresident & CCO
|
Tax withholdingCommon Stock | 433 | $10.55 | $4,568.15 |
DisclosureSEC source: 0001209191-21-060550 · doc4.xml · nonDerivative · entry 2 POYHONEN JOHN · CIK 0001286100 · President & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,019 F2 · acquired: Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions. Read SEC document |
| October 13, 2021 Filed Oct 15, 2021 20:24 UTC |
POYHONEN JOHNPresident & CCO
|
Exercise / conversionCommon Stock | 1,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-060550 · doc4.xml · nonDerivative · entry 1 POYHONEN JOHN · CIK 0001286100 · President & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,452 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| October 13, 2021 Filed Oct 15, 2021 20:23 UTC |
Peraza LisaVP, Chief Accounting Officer
|
GrantRestricted Stock Units · Derivative | 23,424 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-060549 · doc4.xml · derivative · entry 5 Peraza Lisa · CIK 0001828266 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,424 Underlying: Common Stock · 23,424 shares Expires not disclosed F5 · derivative.exercise_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant. F5 · derivative.expiration_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant. Read SEC document |
| October 13, 2021 Filed Oct 15, 2021 20:23 UTC |
Peraza LisaVP, Chief Accounting Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 13,013 | $0.00 Strike: $10.55 | $0.00 |
DisclosureSEC source: 0001209191-21-060549 · doc4.xml · derivative · entry 4 Peraza Lisa · CIK 0001828266 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,013 Underlying: Common Stock · 13,013 shares Expires 2031-10-13 F4 · derivative.exercise_date: The stock option vests and becomes exercisable monthly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that the stock option will be fully vested on the four year anniversary of the date of grant. Read SEC document |
| October 13, 2021 Filed Oct 15, 2021 20:23 UTC |
Peraza LisaVP, Chief Accounting Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 552 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-060549 · doc4.xml · derivative · entry 3 Peraza Lisa · CIK 0001828266 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,625 Underlying: Common Stock · 552 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020). F3 · derivative.expiration_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020). Read SEC document |
| October 13, 2021 Filed Oct 15, 2021 20:23 UTC |
Peraza LisaVP, Chief Accounting Officer
|
Tax withholdingCommon Stock | 191 | $10.55 | $2,015.05 |
DisclosureSEC source: 0001209191-21-060549 · doc4.xml · nonDerivative · entry 2 Peraza Lisa · CIK 0001828266 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,197 F2 · acquired: Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions. Read SEC document |
| October 13, 2021 Filed Oct 15, 2021 20:23 UTC |
Peraza LisaVP, Chief Accounting Officer
|
Exercise / conversionCommon Stock | 552 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-060549 · doc4.xml · nonDerivative · entry 1 Peraza Lisa · CIK 0001828266 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,388 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| October 13, 2021 Filed Oct 15, 2021 20:22 UTC |
MANHARD KIMBERLYDirector · EVP, Drug Development
|
GrantRestricted Stock Units · Derivative | 55,320 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-060547 · doc4.xml · derivative · entry 5 MANHARD KIMBERLY · CIK 0001202094 · Director · EVP, Drug Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,320 Underlying: Common Stock · 55,320 shares Expires not disclosed F5 · derivative.exercise_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant. F5 · derivative.expiration_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant. Read SEC document |
| October 13, 2021 Filed Oct 15, 2021 20:22 UTC |
MANHARD KIMBERLYDirector · EVP, Drug Development
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 92,200 | $0.00 Strike: $10.55 | $0.00 |
DisclosureSEC source: 0001209191-21-060547 · doc4.xml · derivative · entry 4 MANHARD KIMBERLY · CIK 0001202094 · Director · EVP, Drug Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,200 Underlying: Common Stock · 92,200 shares Expires 2031-10-13 F4 · derivative.exercise_date: The stock option vests and becomes exercisable monthly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that the stock option will be fully vested on the four year anniversary of the date of grant. Read SEC document |
| October 13, 2021 Filed Oct 15, 2021 20:22 UTC |
MANHARD KIMBERLYDirector · EVP, Drug Development
|
Exercise / conversionRestricted Stock Units · Derivative | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-060547 · doc4.xml · derivative · entry 3 MANHARD KIMBERLY · CIK 0001202094 · Director · EVP, Drug Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 1,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020). F3 · derivative.expiration_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020). Read SEC document |
| October 13, 2021 Filed Oct 15, 2021 20:22 UTC |
MANHARD KIMBERLYDirector · EVP, Drug Development
|
Tax withholdingCommon Stock | 433 | $10.55 | $4,568.15 |
DisclosureSEC source: 0001209191-21-060547 · doc4.xml · nonDerivative · entry 2 MANHARD KIMBERLY · CIK 0001202094 · Director · EVP, Drug Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,268 F2 · acquired: Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions. Read SEC document |
| October 13, 2021 Filed Oct 15, 2021 20:22 UTC |
MANHARD KIMBERLYDirector · EVP, Drug Development
|
Exercise / conversionCommon Stock | 1,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-060547 · doc4.xml · nonDerivative · entry 1 MANHARD KIMBERLY · CIK 0001202094 · Director · EVP, Drug Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,701 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| September 21, 2021 Filed Sep 23, 2021 20:30 UTC |
Christian WaageDirector
|
SaleCommon Stock | 300 | $12.31 | $3,691.95 |
DisclosureSEC source: 0001209191-21-057420 · doc4.xml · nonDerivative · entry 1 Christian Waage · CIK 0001553179 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,500 F1 · kind: The sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of March 15, 2021. The shares were sold by Mr. Waage to cover his estimated tax liability associated with the vesting of 750 restricted stock units on September 21, 2021. F2 · price: The range of sales prices received was $12.15 to $12.40. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price. Read SEC document |
| September 21, 2021 Filed Sep 23, 2021 20:29 UTC |
Johnson Craig ADirector
|
SaleCommon Stock | 250 | $12.30 | $3,074.10 |
DisclosureSEC source: 0001209191-21-057419 · doc4.xml · nonDerivative · entry 1 Johnson Craig A · CIK 0001370348 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,090 F1 · kind: The sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of March 3, 2021. The shares were sold by Mr. Johnson to cover his estimated tax liability associated with the vesting of 750 restricted stock units (RSUs) on September 21, 2021. F2 · price: The range of sales prices received was $12.15 to $12.40. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price. Read SEC document |
| July 13, 2021 Filed Jul 15, 2021 20:47 UTC |
MANHARD KIMBERLYDirector · EVP, Drug Development
|
Exercise / conversionRestricted Stock Units · Derivative | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-046786 · doc4.xml · derivative · entry 3 MANHARD KIMBERLY · CIK 0001202094 · Director · EVP, Drug Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,250 Underlying: Common Stock · 1,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant (10/13/2020). F3 · derivative.expiration_date: The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant (10/13/2020). Read SEC document |
| July 13, 2021 Filed Jul 15, 2021 20:47 UTC |
MANHARD KIMBERLYDirector · EVP, Drug Development
|
Tax withholdingCommon Stock | 433 | $13.48 | $5,836.84 |
DisclosureSEC source: 0001209191-21-046786 · doc4.xml · nonDerivative · entry 2 MANHARD KIMBERLY · CIK 0001202094 · Director · EVP, Drug Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,451 F2 · acquired: Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions. Read SEC document |
| July 13, 2021 Filed Jul 15, 2021 20:47 UTC |
MANHARD KIMBERLYDirector · EVP, Drug Development
|
Exercise / conversionCommon Stock | 1,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-046786 · doc4.xml · nonDerivative · entry 1 MANHARD KIMBERLY · CIK 0001202094 · Director · EVP, Drug Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| July 13, 2021 Filed Jul 15, 2021 20:52 UTC |
Szekeres David LeslieEVP, Chief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-046791 · doc4.xml · derivative · entry 4 Szekeres David Leslie · CIK 0001602459 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,250 Underlying: Common Stock · 1,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant (10/13/2020). F4 · derivative.expiration_date: The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant (10/13/2020). Read SEC document |
| July 13, 2021 Filed Jul 15, 2021 20:52 UTC |
Szekeres David LeslieEVP, Chief Operating Officer
|
Tax withholdingCommon Stock | 433 | $13.48 | $5,836.84 |
DisclosureSEC source: 0001209191-21-046791 · doc4.xml · nonDerivative · entry 3 Szekeres David Leslie · CIK 0001602459 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,164 F3 · acquired: Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions. Read SEC document |
| July 13, 2021 Filed Jul 15, 2021 20:52 UTC |
Szekeres David LeslieEVP, Chief Operating Officer
|
Exercise / conversionCommon Stock | 1,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-046791 · doc4.xml · nonDerivative · entry 2 Szekeres David Leslie · CIK 0001602459 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,597 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| July 13, 2021 Filed Jul 15, 2021 20:50 UTC |
Quart Barry DDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,645 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-046790 · doc4.xml · derivative · entry 4 Quart Barry D · CIK 0001384243 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,396 Underlying: Common Stock · 3,645 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant (10/13/2020). F4 · derivative.expiration_date: The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant (10/13/2020). Read SEC document |
| July 13, 2021 Filed Jul 15, 2021 20:50 UTC |
Quart Barry DDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 963 | $13.48 | $12,981.24 |
DisclosureSEC source: 0001209191-21-046790 · doc4.xml · nonDerivative · entry 3 Quart Barry D · CIK 0001384243 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,403 F3 · acquired: Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions. Read SEC document |
| July 13, 2021 Filed Jul 15, 2021 20:50 UTC |
Quart Barry DDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 3,645 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-046790 · doc4.xml · nonDerivative · entry 2 Quart Barry D · CIK 0001384243 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,366 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| July 13, 2021 Filed Jul 15, 2021 20:49 UTC |
POYHONEN JOHNPresident & CCO
|
Exercise / conversionRestricted Stock Units · Derivative | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-046789 · doc4.xml · derivative · entry 4 POYHONEN JOHN · CIK 0001286100 · President & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,250 Underlying: Common Stock · 1,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant (10/13/2020). F4 · derivative.expiration_date: The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant (10/13/2020). Read SEC document |
| July 13, 2021 Filed Jul 15, 2021 20:49 UTC |
POYHONEN JOHNPresident & CCO
|
Tax withholdingCommon Stock | 433 | $13.48 | $5,836.84 |
DisclosureSEC source: 0001209191-21-046789 · doc4.xml · nonDerivative · entry 3 POYHONEN JOHN · CIK 0001286100 · President & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,202 F3 · acquired: Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions. Read SEC document |
| July 13, 2021 Filed Jul 15, 2021 20:49 UTC |
POYHONEN JOHNPresident & CCO
|
Exercise / conversionCommon Stock | 1,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-046789 · doc4.xml · nonDerivative · entry 2 POYHONEN JOHN · CIK 0001286100 · President & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,635 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| July 13, 2021 Filed Jul 15, 2021 20:48 UTC |
Peraza LisaVP, Chief Accounting Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 552 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-046788 · doc4.xml · derivative · entry 4 Peraza Lisa · CIK 0001828266 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,177 Underlying: Common Stock · 552 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant (10/13/2020). F4 · derivative.expiration_date: The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant (10/13/2020). Read SEC document |
| July 13, 2021 Filed Jul 15, 2021 20:48 UTC |
Peraza LisaVP, Chief Accounting Officer
|
Tax withholdingCommon Stock | 191 | $13.48 | $2,574.68 |
DisclosureSEC source: 0001209191-21-046788 · doc4.xml · nonDerivative · entry 3 Peraza Lisa · CIK 0001828266 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,836 F3 · acquired: Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions. Read SEC document |
| July 13, 2021 Filed Jul 15, 2021 20:48 UTC |
Peraza LisaVP, Chief Accounting Officer
|
Exercise / conversionCommon Stock | 552 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-046788 · doc4.xml · nonDerivative · entry 2 Peraza Lisa · CIK 0001828266 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,027 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| June 21, 2021 Filed Jun 22, 2021 21:06 UTC |
Christian WaageDirector
|
SaleCommon Stock | 300 | $15.20 | $4,559.19 |
DisclosureSEC source: 0001209191-21-042433 · doc4.xml · nonDerivative · entry 1 Christian Waage · CIK 0001553179 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,800 F1 · kind: The sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of March 15, 2021. F2 · price: The range of sales prices received was $14.89 to $15.42. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price. Read SEC document |
| June 21, 2021 Filed Jun 22, 2021 21:05 UTC |
Johnson Craig ADirector
|
SaleCommon Stock | 250 | $15.20 | $3,800.60 |
DisclosureSEC source: 0001209191-21-042429 · doc4.xml · nonDerivative · entry 1 Johnson Craig A · CIK 0001370348 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,340 F1 · kind: The sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of March 3, 2021. F2 · price: The range of sales prices received was $14.89 to $15.42. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price. Read SEC document |
| May 03, 2021 Filed May 4, 2021 22:03 UTC |
MANHARD KIMBERLYDirector · EVP, Drug Development
|
SaleCommon Stock | 1,529 | $17.66 | $27,008.71 |
DisclosureSEC source: 0001209191-21-030014 · doc4.xml · nonDerivative · entry 2 MANHARD KIMBERLY · CIK 0001202094 · Director · EVP, Drug Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,634 F2 · kind: The sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of September 15, 2020. F3 · price: The range of sales prices received was $17.46 to $17.84. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price. Read SEC document |
| April 30, 2021 Filed May 4, 2021 22:03 UTC |
MANHARD KIMBERLYDirector · EVP, Drug Development
|
OtherCommon Stock | 1,529 | $13.90 | $21,249.28 |
DisclosureSEC source: 0001209191-21-030014 · doc4.xml · nonDerivative · entry 1 MANHARD KIMBERLY · CIK 0001202094 · Director · EVP, Drug Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,163 F1 · kind: Represents shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on April 30, 2021. Read SEC document |
| April 30, 2021 Filed Jul 15, 2021 20:52 UTC |
Szekeres David LeslieEVP, Chief Operating Officer
|
OtherCommon Stock | 1,530 | $13.90 | $21,263.18 |
DisclosureSEC source: 0001209191-21-046791 · doc4.xml · nonDerivative · entry 1 Szekeres David Leslie · CIK 0001602459 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,347 F1 · kind: Represents shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on April 30, 2021. Read SEC document |
| April 30, 2021 Filed Jul 15, 2021 20:50 UTC |
Quart Barry DDirector · Chief Executive Officer
|
OtherCommon Stock | 1,529 | $13.90 | $21,249.28 |
DisclosureSEC source: 0001209191-21-046790 · doc4.xml · nonDerivative · entry 1 Quart Barry D · CIK 0001384243 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,721 F1 · kind: Represents shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on April 30, 2021. Read SEC document |
| April 30, 2021 Filed Jul 15, 2021 20:49 UTC |
POYHONEN JOHNPresident & CCO
|
OtherCommon Stock | 971 | $13.90 | $13,494.47 |
DisclosureSEC source: 0001209191-21-046789 · doc4.xml · nonDerivative · entry 1 POYHONEN JOHN · CIK 0001286100 · President & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,385 F1 · kind: Represents shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on April 30, 2021. Read SEC document |
| April 30, 2021 Filed Jul 15, 2021 20:48 UTC |
Peraza LisaVP, Chief Accounting Officer
|
OtherCommon Stock | 1,530 | $13.90 | $21,263.18 |
DisclosureSEC source: 0001209191-21-046788 · doc4.xml · nonDerivative · entry 1 Peraza Lisa · CIK 0001828266 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,475 F1 · kind: Represents shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on April 30, 2021. Read SEC document |
| April 15, 2021 Filed Apr 17, 2021 00:59 UTC |
Christian WaageDirector
|
SaleCommon Stock | 300 | $17.51 | $5,253.78 |
DisclosureSEC source: 0001209191-21-027119 · doc4.xml · nonDerivative · entry 1 Christian Waage · CIK 0001553179 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,100 F1 · kind: The sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of March 15, 2021. F2 · price: The range of sales prices received was $17.295 to $17.69. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price. Read SEC document |
| April 13, 2021 Filed Apr 15, 2021 20:55 UTC |
Szekeres David LeslieEVP, Chief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026845 · doc4.xml · derivative · entry 3 Szekeres David Leslie · CIK 0001602459 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Common Stock · 1,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant (10/13/2020). F3 · derivative.expiration_date: The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant (10/13/2020). Read SEC document |
| April 13, 2021 Filed Apr 15, 2021 20:55 UTC |
Szekeres David LeslieEVP, Chief Operating Officer
|
Tax withholdingCommon Stock | 433 | $16.66 | $7,213.78 |
DisclosureSEC source: 0001209191-21-026845 · doc4.xml · nonDerivative · entry 2 Szekeres David Leslie · CIK 0001602459 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 817 F2 · acquired: Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions. Read SEC document |
| April 13, 2021 Filed Apr 15, 2021 20:55 UTC |
Szekeres David LeslieEVP, Chief Operating Officer
|
Exercise / conversionCommon Stock | 1,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-026845 · doc4.xml · nonDerivative · entry 1 Szekeres David Leslie · CIK 0001602459 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| April 13, 2021 Filed Apr 15, 2021 20:54 UTC |
Quart Barry DDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,646 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026844 · doc4.xml · derivative · entry 6 Quart Barry D · CIK 0001384243 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,041 Underlying: Common Stock · 3,646 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F5 · derivative.exercise_date: The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant (10/13/2020). F5 · derivative.expiration_date: The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant (10/13/2020). Read SEC document |
| April 13, 2021 Filed Apr 15, 2021 20:54 UTC |
Quart Barry DDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 963 | $16.66 | $16,043.58 |
DisclosureSEC source: 0001209191-21-026844 · doc4.xml · nonDerivative · entry 5 Quart Barry D · CIK 0001384243 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,192 F4 · acquired: Represents the withholding by the Company of certain of the vested shares of restricted stock units to satisfy the minimum statutory tax obligations applicable to such transactions. Read SEC document |
| April 13, 2021 Filed Apr 15, 2021 20:54 UTC |
Quart Barry DDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 3,646 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-026844 · doc4.xml · nonDerivative · entry 4 Quart Barry D · CIK 0001384243 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,155 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| April 13, 2021 Filed Apr 15, 2021 20:53 UTC |
POYHONEN JOHNPresident & CCO
|
Exercise / conversionRestricted Stock Units · Derivative | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026843 · doc4.xml · derivative · entry 3 POYHONEN JOHN · CIK 0001286100 · President & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Common Stock · 1,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant (10/13/2020). F3 · derivative.expiration_date: The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant (10/13/2020). Read SEC document |
| April 13, 2021 Filed Apr 15, 2021 20:53 UTC |
POYHONEN JOHNPresident & CCO
|
Tax withholdingCommon Stock | 433 | $16.66 | $7,213.78 |
DisclosureSEC source: 0001209191-21-026843 · doc4.xml · nonDerivative · entry 2 POYHONEN JOHN · CIK 0001286100 · President & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,414 F2 · acquired: Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions. Read SEC document |
| April 13, 2021 Filed Apr 15, 2021 20:53 UTC |
POYHONEN JOHNPresident & CCO
|
Exercise / conversionCommon Stock | 1,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-026843 · doc4.xml · nonDerivative · entry 1 POYHONEN JOHN · CIK 0001286100 · President & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,847 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| April 13, 2021 Filed Apr 15, 2021 20:52 UTC |
Peraza LisaVP, Chief Accounting Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 552 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-026842 · doc4.xml · derivative · entry 3 Peraza Lisa · CIK 0001828266 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,729 Underlying: Common Stock · 552 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant (10/13/2020). F3 · derivative.expiration_date: The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant (10/13/2020). Read SEC document |
| April 13, 2021 Filed Apr 15, 2021 20:52 UTC |
Peraza LisaVP, Chief Accounting Officer
|
Tax withholdingCommon Stock | 191 | $16.66 | $3,182.06 |
DisclosureSEC source: 0001209191-21-026842 · doc4.xml · nonDerivative · entry 2 Peraza Lisa · CIK 0001828266 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,945 F2 · acquired: Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.